Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „encorafenib“
Suchtreffer
Begriffe & Kennungen
Braftovi · 4.8 · When encorafenib was used at a dose of 300 mg once daily in combination with binimetinib 45 mg twice daily (Co
Eintrag öffnenEncorafenib
Eintrag öffnenErbitux · 4.8 · 10 Cetuximab Cetuximab in Cetuximab in combination combination with with Encorafenib and Encorafenib FOLFOX (n
Eintrag öffnenErbitux · 4.8 · 11 Cetuximab Cetuximab in Cetuximab in combination combination with with Encorafenib and Encorafenib FOLFOX (n
Eintrag öffnenErbitux · 4.8 · 9 Table: Adverse reactions Cetuximab Cetuximab in Cetuximab in combination combination with with Encorafenib a
Eintrag öffnenErbitux · 4.8 · In combination with encorafenib and FOLFOX or encorafenib, no new adverse reactions other than those currently
Eintrag öffnenErbitux · 4.8 · The safety of cetuximab in combination with encorafenib (300 mg orally once daily) (dosed as per its SmPC) was
Eintrag öffnenErbitux · 4.8 · The safety of cetuximab in combination with encorafenib (300 mg orally once daily) and FOLFOX was evaluated in
Eintrag öffnenMektovi · 4.5 · While encorafenib is a relatively potent reversible inhibitor of UGT1A1, no differences in binimetinib exposur
Eintrag öffnenMektovi · 4.8 · 14 Rhabdomyolysis was reported in 0.3% (1/372) of patients treated with encorafenib in combination with binime
Eintrag öffnenMektovi · 4.8 · Cutaneous malignancies CuSCC was reported when binimetinib was used in combination with encorafenib (see secti
Eintrag öffnenMektovi · 4.8 · Facial paresis Facial paresis was reported when binimetinib was used in combination with encorafenib (see sect
Eintrag öffnenMektovi · 4.8 · Pancreatitis Pancreatitis was reported when binimetinib was used in combination with encorafenib (see section
Eintrag öffnenMektovi · 4.8 · Table 3: Adverse reactions occurring in patients receiving binimetinib in combination with encorafenib at the
Eintrag öffnenMektovi · 4.8 · The safety of binimetinib (45 mg orally twice daily) in combination with encorafenib (450 mg orally once daily
Eintrag öffnenMektovi · 4.8 · The safety of encorafenib (300 mg orally once daily) in combination with binimetinib (45 mg orally twice daily
Eintrag öffnenMektovi · 4.8 · Uveitis was also reported when binimetinib was used in combination with encorafenib (see section 4.8 of encora
Eintrag öffnenMektovi · 4.8 · When encorafenib was used at a dose of 300 mg once daily in combination with binimetinib 45 mg twice daily (Co
Eintrag öffnenNorvir · 4.5 · Encorafenib Serum concentrations may be increased when co-administered with ritonavir which may increase the r
Eintrag öffnenNorvir · 4.5 · Encorafenib Serum concentrations may be increased when co-administered with ritonavir which may increase the r
Eintrag öffnen